Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,22968,36,12.69 [2.05-78.64],0.0063228454973897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,26503,40,3.95 [2.43-6.42],2.92701043109888e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,26202,40,5.40 [2.47-11.80],2.3206468284263062e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,26416,40,1.89 [1.28-2.79],0.0012707648184849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,22213,35,2.38 [1.44-3.93],0.000742069446539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,26236,40,6.11 [3.95-9.45],4.604762662586903e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,22293,36,2.24 [1.46-3.46],0.0002537737500221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22858,36,4.04 [2.31-7.08],1.018018064854539e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,22293,36,2.41 [1.34-4.31],0.0031320403018144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,26739,40,4.96 [1.60-15.38],0.0055988053152567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,26305,39,2.90 [1.45-5.83],0.0027044910209488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,22926,36,5.64 [3.17-10.02],3.760949051159727e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,22858,36,2.72 [1.66-4.47],7.57202605931802e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,26539,40,8.91 [4.20-18.91],1.1865448066145241e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,26587,39,4.51 [2.41-8.42],2.294139023705655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,22945,37,3.89 [1.43-10.59],0.0077817985161494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,26305,39,2.34 [1.89-2.90],1.0042504427847556e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,26416,40,0.43 [0.29-0.64],2.352683365543012e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,26655,42,25.24 [8.84-72.10],1.6551197272410299e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,25602,41,2.05 [1.63-2.59],1.5530205494744755e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,25754,40,1.66 [1.19-2.32],0.0026885786464336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,26539,40,3.88 [2.49-6.07],2.5853454647475903e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,26732,42,2.44 [1.44-4.13],0.0009311079929383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,26739,40,5.05 [1.50-16.93],0.0087706609024141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",26305,39,1.45 [1.14-1.85],0.0027873318888143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,26622,42,25.46 [8.54-75.92],6.3419718421117475e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,26305,39,4.76 [1.65-13.75],0.0039582966481914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,26314,40,2.46 [1.33-4.56],0.0041638407636589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,26655,42,6.30 [3.38-11.76],7.271175385919685e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,26498,40,4.20 [2.34-7.55],1.619107485382683e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,26655,42,3.33 [2.12-5.22],1.616403006462709e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,25812,41,1.68 [1.31-2.16],5.287119401385218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,26487,40,5.04 [2.28-11.14],6.379157906994491e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,26416,40,0.43 [0.24-0.76],0.0033251334143201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,22968,36,3.38 [2.31-4.94],3.076688266040783e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,26305,39,4.04 [2.69-6.07],1.8243953637089203e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,26246,40,7.26 [4.24-12.42],5.060839357235406e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,22963,37,5.25 [1.76-15.69],0.0030021585882607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",22968,36,17.58 [4.68-66.06],2.201953548929675e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,26487,40,3.91 [1.56-9.80],0.0036736113268624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,22968,36,1.64 [1.18-2.26],0.0028399245094355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",22310,34,11.45 [6.34-20.69],6.473035655432643e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",26539,40,6.54 [2.68-15.99],3.764980779139412e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,25789,40,1.65 [1.23-2.21],0.0008989352040653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,25789,40,2.94 [1.80-4.80],1.7353079491127424e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,26246,40,0.44 [0.30-0.64],1.9641052043984137e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",26402,41,3.42 [1.60-7.29],0.0014477442057716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,22926,36,0.60 [0.42-0.85],0.0045172379505746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,22429,37,6.61 [3.48-12.55],7.809942996844162e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,22968,36,7.38 [1.81-30.15],0.0053986966358111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,26539,40,6.07 [3.01-12.25],4.801396231912366e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,26402,41,2.91 [1.80-4.72],1.4131932193451416e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,26487,40,3.21 [2.14-4.81],1.5211141554821772e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,26454,40,20.24 [7.82-52.41],5.710787369289275e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,22430,34,8.77 [4.55-16.88],8.24703748561028e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,25789,40,2.12 [1.33-3.39],0.0015637152737289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,26305,39,3.52 [2.37-5.21],3.8919657177025903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,26321,41,0.32 [0.21-0.50],2.0631421272879321e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,26655,42,3.47 [2.37-5.07],1.3936507259018239e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,25812,41,2.39 [1.59-3.59],3.031529310509611e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,26203,40,2.02 [1.53-2.67],6.824824815462654e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,26350,40,6.95 [1.83-26.33],0.0043428847256494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,26384,40,2.38 [1.71-3.30],2.578159952701944e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,26732,42,4.67 [2.31-9.46],1.8553217092453663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,26739,40,4.16 [2.53-6.85],2.0338977886519903e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,26739,40,2.54 [1.46-4.43],0.0010291597239587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,26732,42,1.63 [1.31-2.02],7.754150839239725e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,26539,40,2.17 [1.45-3.26],0.000185727124416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,26116,39,1.87 [1.17-2.98],0.0085486896597179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,26402,41,1.38 [1.08-1.76],0.0090189018871127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,26402,41,1.65 [1.24-2.19],0.0006045291352071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,26269,39,1.91 [1.23-2.96],0.003736753961591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,26655,42,2.57 [1.57-4.23],0.0001900020380748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,26246,40,0.35 [0.18-0.67],0.0015191789712731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,26404,41,2.98 [1.31-6.74],0.0088775463499797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,25824,40,2.62 [1.47-4.66],0.001060466630971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,26732,42,2.49 [1.59-3.89],6.543912999807174e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,26487,40,3.02 [1.73-5.25],9.41137084978889e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,26404,41,2.02 [1.40-2.94],0.0002020263202816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,22213,35,1.80 [1.20-2.71],0.0046848545668018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,25861,38,5.06 [2.73-9.41],2.848193380797761e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,26732,42,4.21 [1.94-9.16],0.0002850549882883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,26490,42,4.41 [2.98-6.53],1.412698687790283e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,26246,40,3.37 [1.77-6.40],0.0002113861927242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,26400,39,7.92 [3.85-16.31],1.9449318602629385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,25789,40,3.03 [1.77-5.20],5.423571094367459e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,22429,37,6.59 [2.67-16.22],4.1433497825586846e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,26677,41,3.40 [1.62-7.13],0.0011766460588872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,26572,42,3.25 [1.85-5.70],3.825405834127193e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,26305,39,3.48 [1.98-6.12],1.5149629522382948e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,26359,41,2.53 [1.65-3.87],1.9364842842707543e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,26401,40,2.17 [1.43-3.30],0.0002815139656086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,26230,40,3.31 [1.62-6.75],0.0010325064667864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,26498,40,9.66 [4.78-19.52],2.668414407423065e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,26622,42,4.46 [2.62-7.62],4.1426363425024586e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,25416,37,5.02 [2.61-9.64],1.300319405326885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,26677,41,6.41 [3.37-12.20],1.4850362891217076e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,26732,42,3.43 [2.21-5.33],3.7859291469716025e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,22945,37,5.82 [3.36-10.07],3.2183210181679583e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,26402,41,3.18 [1.91-5.30],8.60023235041395e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,26677,41,2.56 [1.51-4.32],0.0004753202239424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,26246,40,3.49 [2.45-4.98],4.869141921699944e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,25509,38,2.04 [1.48-2.80],1.2844901030041974e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,26634,41,1.55 [1.15-2.10],0.004580494172187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,26416,40,1.96 [1.35-2.84],0.0003776431054544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,26416,40,8.31 [4.02-17.17],1.0765374484016388e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,26450,42,4.99 [1.60-15.58],0.0056178843098195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,25434,40,2.06 [1.47-2.91],3.244257037714394e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22926,36,2.15 [1.58-2.92],1.0913775503612262e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,22293,36,2.25 [1.48-3.42],0.0001413136144674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,26462,37,1.45 [1.12-1.88],0.0049376037119441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,26305,39,2.09 [1.39-3.14],0.0003914879366461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,22541,36,6.36 [2.32-17.42],0.0003169928838244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,25789,40,1.91 [1.25-2.92],0.0029464216993497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,21636,35,6.59 [2.18-19.91],0.0008273783587519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,22968,36,9.55 [2.19-41.66],0.0026820099416586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,26404,41,2.13 [1.54-2.94],4.292847033087764e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,26416,40,4.62 [2.59-8.22],1.985792816535461e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,22429,37,0.60 [0.44-0.81],0.0010259423526489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22882,35,3.34 [2.17-5.15],4.8873242807233134e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,22835,37,2.35 [1.27-4.36],0.0068367442304319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,22926,36,1.85 [1.47-2.34],1.9386495042859245e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,25800,39,1.76 [1.34-2.32],5.289797805279559e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,26498,40,3.81 [1.69-8.57],0.0012136373131705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,22926,36,2.63 [1.74-3.98],4.409685079718067e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,26587,42,4.18 [2.62-6.68],2.0911606951516288e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,26246,40,3.09 [1.42-6.74],0.0044742070109598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,26402,41,2.09 [1.42-3.06],0.0001768397800599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,26317,40,3.61 [1.70-7.67],0.000858196614552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,25789,40,2.75 [1.71-4.42],2.764301099403825e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,26655,42,4.53 [1.50-13.66],0.0073911323689306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,26732,42,2.28 [1.42-3.64],0.0006078364952768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,26374,40,0.32 [0.17-0.59],0.0003496997560488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNDP1,Beta-Ala-His dipeptidase,26487,40,3.48 [1.70-7.12],0.0006687149990846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,26404,41,6.09 [2.42-15.31],0.0001256673467814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,26507,40,0.58 [0.41-0.83],0.002310003127254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,22945,37,2.54 [1.47-4.42],0.000902451854429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,22926,36,0.33 [0.14-0.76],0.0090521634627364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,26499,39,15.38 [5.85-40.46],3.0138076201596825e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,22429,37,2.74 [1.64-4.58],0.0001213859107012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,26739,40,3.26 [1.83-5.79],5.8237785109474345e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,26400,39,8.04 [3.87-16.69],2.218222661224282e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,26583,41,2.03 [1.41-2.93],0.0001434716185027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,26562,40,7.86 [3.98-15.52],2.825334158231426e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,22945,37,4.03 [1.58-10.30],0.0035845855834701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,22429,37,5.88 [2.63-13.14],1.619774734998867e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,26498,40,2.12 [1.37-3.28],0.0008023246645798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,26400,39,9.15 [3.42-24.51],1.067314264952574e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,26539,40,6.99 [2.14-22.79],0.0012749669053179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,26246,40,3.00 [1.79-5.04],3.148414707706641e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,26539,40,6.86 [2.94-15.97],8.099624349594477e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,22963,37,3.11 [1.89-5.14],8.781400280364873e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,26447,40,4.67 [2.34-9.31],1.2215794238403757e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,26442,40,1.38 [1.12-1.70],0.0022106891837555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,24627,36,2.54 [1.69-3.81],7.295126573496568e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,22429,37,2.65 [1.52-4.61],0.0005660815470059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,26416,40,4.54 [1.60-12.91],0.0045582052356979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,26732,42,3.91 [1.88-8.15],0.0002708566183381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,20851,30,14.74 [4.16-52.15],3.010683641035286e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,26388,40,5.22 [2.29-11.92],8.748331710523709e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,26686,40,6.69 [2.42-18.49],0.0002478638295793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,26732,42,1.93 [1.29-2.89],0.0013325323708274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,26732,42,1.56 [1.12-2.19],0.0093351655835675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,26215,42,1.44 [1.13-1.84],0.0033985007738286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,26539,40,2.44 [1.45-4.10],0.0007732401426483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",26490,42,3.92 [2.53-6.06],8.44042183876239e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,26677,41,4.95 [1.90-12.86],0.0010368725978702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,22134,36,2.67 [1.80-3.97],9.805969891103031e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,26026,39,1.40 [1.16-1.70],0.0005997562508387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,26739,40,3.40 [1.40-8.26],0.0070219895807264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,26197,40,2.77 [1.82-4.22],2.2076699971301377e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,26490,42,6.64 [3.49-12.62],7.70712786993235e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,22310,34,0.41 [0.31-0.54],1.924039910723168e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,26402,41,2.47 [1.43-4.27],0.0011508472574033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,26305,39,5.46 [2.71-11.03],2.124781477192683e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,26739,40,6.42 [1.92-21.51],0.0025849994576544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,26583,42,1.72 [1.20-2.45],0.0028209838291567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,26090,40,4.08 [2.21-7.53],6.804484248731178e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,22907,37,6.08 [2.80-13.21],5.065947084613817e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,22798,37,2.22 [1.38-3.57],0.000966694597363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,26621,42,4.18 [2.18-8.03],1.7267542623550997e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,26655,42,4.03 [2.57-6.32],1.201514318509316e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,22858,36,2.95 [1.79-4.85],2.199731701815125e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,26435,40,4.01 [1.95-8.24],0.0001538558031668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,26356,41,3.98 [2.03-7.79],5.51536335880292e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,26202,40,7.09 [4.36-11.53],2.688618716291872e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,25789,40,2.47 [1.38-4.41],0.002305061245026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,25658,38,1.64 [1.17-2.30],0.0039458645191282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,25470,39,4.27 [2.55-7.14],3.297916241515713e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,26739,40,5.43 [2.56-11.50],9.986330852914009e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,26617,42,2.79 [1.33-5.86],0.0068830175313346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,26301,39,9.91 [3.25-30.26],5.6320242402521866e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,26490,42,5.59 [2.08-15.03],0.0006541482954981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,22293,36,2.39 [1.24-4.63],0.009332111618084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,26739,40,3.59 [1.92-6.70],6.224854528721202e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,22625,36,1.88 [1.26-2.79],0.0018458349352697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,26454,40,9.93 [2.47-39.95],0.0012260054509928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",26400,39,2.24 [1.76-2.87],1.0774440817052312e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",26416,40,1.63 [1.18-2.26],0.0029219995318872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",22945,37,2.37 [1.66-3.38],1.7808742371053288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",26739,40,3.64 [2.48-5.36],5.383119620709273e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,26305,39,5.91 [2.58-13.54],2.670665811945726e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,26384,40,10.77 [6.01-19.29],1.2965423341103196e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,22858,36,2.58 [1.74-3.85],2.8646189535912808e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,26640,40,1.97 [1.30-2.99],0.0013231887418944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,22945,37,2.13 [1.44-3.13],0.0001367140547238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,26402,41,2.48 [1.40-4.37],0.0017383776537595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,22925,37,2.37 [1.23-4.55],0.009834024423918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,26619,42,2.27 [1.47-3.52],0.0002458386808549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,26402,41,2.04 [1.36-3.07],0.0006257584132583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,25789,40,1.93 [1.43-2.61],1.9818427265778705e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,26621,42,1.37 [1.13-1.67],0.0014743931198251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,26611,42,1.50 [1.11-2.02],0.007556833206786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,25930,40,2.62 [1.62-4.22],7.669808388056892e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,26490,42,0.47 [0.32-0.71],0.0002661953833263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,26490,42,11.30 [5.34-23.90],2.3075323456101847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,26360,42,4.17 [2.17-8.03],1.9341464610718527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,22310,34,1.99 [1.39-2.85],0.0001716355427285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,26362,39,6.99 [4.00-12.22],9.238004038427911e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,22293,36,1.75 [1.15-2.65],0.0085109084159978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,26305,39,4.71 [1.97-11.26],0.0004977118326787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,26305,39,5.06 [1.58-16.19],0.0063414934814554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,22882,35,1.43 [1.19-1.72],0.0001094470583117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,25789,40,1.76 [1.39-2.24],3.2413844284144264e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",26305,39,4.13 [1.94-8.77],0.0002287447982991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,26739,40,2.77 [2.26-3.40],1.0397150043241316e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,26621,42,6.48 [3.32-12.66],4.461216954557216e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,26356,41,2.02 [1.35-3.02],0.0006340294235516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,26246,40,4.74 [2.67-8.44],1.2062917414853192e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP8,GTPase IMAP family member 8,22139,37,2.13 [1.46-3.10],8.223003565212587e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,22310,34,2.31 [1.26-4.21],0.0065180599588022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,22882,35,4.91 [2.26-10.68],6.042993428430652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,22382,36,2.93 [1.46-5.90],0.0025353396414542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,22387,36,1.95 [1.32-2.89],0.000837285360444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,26732,42,0.52 [0.32-0.84],0.0082265339589241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,26677,41,11.35 [5.04-25.58],4.6392497109287255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,26305,39,0.62 [0.50-0.78],2.6475038876671315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,25946,40,3.31 [2.23-4.90],2.526175787078127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,26271,41,5.15 [2.31-11.48],6.278669618036292e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",26305,39,1.77 [1.24-2.53],0.0017178686330239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,26280,41,4.26 [2.46-7.35],2.067120755475425e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,26503,40,1.94 [1.26-2.97],0.0024721912216485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,26622,42,1.70 [1.39-2.08],2.2639991469603683e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,26404,41,4.47 [2.58-7.74],9.337374951015973e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,22429,37,4.28 [1.49-12.25],0.0068342521001973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,26732,42,3.12 [1.81-5.35],3.912893721507653e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,22844,35,1.84 [1.20-2.81],0.0047887868159348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,22907,37,2.45 [1.76-3.40],1.009477972834639e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",26402,41,4.88 [2.38-10.00],1.45996030289866e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,22627,36,1.58 [1.14-2.20],0.0062867408667544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,26402,41,0.31 [0.16-0.61],0.0005861550434716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,26655,42,3.27 [1.90-5.64],1.9077209276038766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,26189,40,3.27 [1.58-6.77],0.0013604161043369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,26739,40,7.06 [2.27-21.97],0.0007361039803519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,26281,40,4.19 [1.83-9.56],0.0006774584157704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,26739,40,4.16 [1.61-10.76],0.0032581655053015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,26402,41,0.43 [0.26-0.72],0.0014396485908736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,26655,42,4.52 [2.37-8.63],4.854749246339205e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,22333,35,2.60 [1.32-5.11],0.005783216827999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,26539,40,2.46 [1.25-4.83],0.009201249154227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,26246,40,2.07 [1.29-3.32],0.0025610972616217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,26404,41,6.78 [3.21-14.32],5.381231153908382e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,26076,41,3.22 [2.24-4.63],2.4487260042680126e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,26739,40,3.25 [2.26-4.67],2.1201090257666663e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,26416,40,3.02 [1.68-5.42],0.0002128300082301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,22935,36,2.32 [1.31-4.09],0.0037635126402079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,26305,39,3.29 [2.33-4.64],1.3792489789995684e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,26416,40,4.98 [2.54-9.77],2.967534350538733e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,22945,37,2.16 [1.60-2.93],6.255566171991969e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,26539,40,4.03 [2.69-6.02],1.1185189823299066e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,26305,39,2.12 [1.52-2.95],9.980506667383522e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,26732,42,2.26 [1.39-3.67],0.0010377371924418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,25930,40,3.25 [1.59-6.66],0.0012710606630004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,25930,40,3.13 [1.41-6.91],0.0048512416667896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,25930,40,1.95 [1.48-2.56],1.6703743671713425e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,26305,39,2.49 [1.62-3.82],3.1843664641144455e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,26732,42,13.14 [6.27-27.55],8.95512329585162e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18RAP,Interleukin-18 receptor accessory protein,26083,39,0.74 [0.60-0.92],0.0062388318122433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,25768,39,1.63 [1.25-2.13],0.0002973784577642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,26356,41,1.88 [1.19-2.97],0.0067668121285447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,26354,39,26.78 [7.00-102.54],1.5872064153384762e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,26358,40,2.14 [1.58-2.90],8.292596571141242e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,26236,40,2.93 [1.77-4.85],3.121960593220209e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,26402,41,2.40 [1.25-4.60],0.0082038227448052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,26404,41,0.52 [0.31-0.85],0.0090536625841501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,22835,37,2.52 [1.79-3.55],1.3573491400857996e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,22429,37,2.62 [1.52-4.52],0.0005341083100821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,26404,41,4.92 [2.18-11.13],0.0001271704494419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,22293,36,35.79 [7.00-183.01],1.7333207044965704e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,26404,41,6.26 [2.28-17.21],0.0003728205625591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,26404,41,3.23 [1.49-7.03],0.0030321981028465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,26246,38,4.27 [2.36-7.73],1.5774991593172292e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,26655,42,3.21 [1.98-5.20],2.1765662363395263e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,22926,36,3.42 [1.97-5.96],1.3453826786060335e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,26487,40,2.82 [1.37-5.79],0.0048406702270568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,26236,42,3.25 [2.10-5.03],1.342104120413254e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,26655,42,1.85 [1.38-2.49],4.706931218845404e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,26732,42,11.43 [6.42-20.33],1.1316683632684775e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,26732,42,2.99 [1.73-5.20],9.627507710894772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,22293,36,2.15 [1.59-2.92],8.154078389081715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,22882,35,2.58 [1.66-4.02],2.7297094345753936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",26305,39,1.53 [1.17-2.00],0.0017503626398389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",26368,41,2.67 [1.99-3.58],5.5706148241100886e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",22212,34,1.47 [1.21-1.79],0.0001089540697927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,26305,39,2.50 [1.76-3.54],2.767863231148073e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,26400,39,2.84 [1.93-4.19],1.4032844266052444e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,22310,34,5.03 [1.75-14.45],0.0027237969599544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,22299,36,1.87 [1.24-2.81],0.0027905970437981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,26684,42,2.22 [1.37-3.61],0.0012877005249152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,26203,40,4.13 [2.37-7.21],5.998160288450253e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,22907,37,1.70 [1.24-2.32],0.0009658417123911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,25569,39,2.72 [1.63-4.54],0.0001235986855298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,22968,36,2.92 [1.64-5.19],0.0002625067287367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,26400,39,5.05 [3.47-7.35],2.4211748585539467e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,26401,40,5.51 [2.69-11.28],3.0820071481702773e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,26539,40,2.90 [1.48-5.66],0.0018407709587859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,26402,41,7.21 [3.90-13.33],2.8117944100986117e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,26384,40,4.22 [2.47-7.22],1.4386334399832168e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,26739,40,4.01 [1.44-11.11],0.0076443189679439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIPF,Gastric triacylglycerol lipase,22310,34,1.73 [1.17-2.55],0.0057308648460256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,26416,40,0.47 [0.31-0.70],0.0002156765869356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,25579,39,3.54 [2.46-5.08],8.228681326426519e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,26588,42,2.66 [1.28-5.52],0.0087035771108049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,26416,40,3.83 [1.99-7.35],5.677667088624196e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,26655,42,0.38 [0.22-0.66],0.0006784346506327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,26739,40,4.76 [2.36-9.61],1.2979037473984282e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,26253,39,4.52 [2.31-8.85],1.0532336387987146e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,26147,41,5.42 [2.35-12.52],7.600625431061443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,26246,40,3.18 [2.00-5.04],9.329466159519412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD3,Ly6/PLAUR domain-containing protein 3,26295,42,3.42 [1.66-7.04],0.0008424809578258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,26490,42,4.88 [2.25-10.57],5.818024276315303e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,22882,35,2.05 [1.21-3.47],0.0078194877418199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,22293,36,1.50 [1.11-2.02],0.0084524477558027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,26402,42,1.72 [1.25-2.36],0.0008288045319292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,22429,37,0.40 [0.20-0.77],0.0060270813456797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,22429,37,5.26 [2.07-13.38],0.0004958503346848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,26404,41,4.15 [2.75-6.26],1.3276609377119167e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,25930,40,2.18 [1.34-3.53],0.0016564446099971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,26402,41,1.57 [1.15-2.15],0.0049993405791294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,26375,39,2.00 [1.36-2.96],0.0004920956928761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,26461,42,2.91 [1.88-4.51],1.889151719573524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,25904,40,3.23 [1.83-5.70],5.015272480337816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,22963,37,9.70 [4.26-22.12],6.489862661589336e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",22102,37,3.15 [1.51-6.54],0.0021172116224173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,26269,39,1.85 [1.21-2.84],0.0046019103996471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,26677,41,3.92 [2.38-6.44],7.624692348994198e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,25812,41,7.16 [4.95-10.35],1.5995250650694096e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,25930,40,1.57 [1.17-2.09],0.0022566757470357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,22429,37,0.50 [0.31-0.80],0.0038044874893579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",22945,37,1.66 [1.18-2.32],0.0033366977140453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,22310,34,1.70 [1.16-2.51],0.0070756643075442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,26489,39,2.04 [1.25-3.33],0.0042544716703749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,26490,42,5.39 [2.44-11.89],3.0154382281386088e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,26677,41,0.55 [0.40-0.76],0.0002673403746825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,26366,41,3.53 [1.72-7.25],0.0005937139972682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22858,36,3.36 [1.59-7.11],0.0015452513916193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,26655,42,3.54 [1.36-9.20],0.0095182397355488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,26384,40,6.53 [3.45-12.35],8.141861970096198e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,26490,42,2.83 [1.71-4.66],4.734283316360162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,26490,42,0.31 [0.17-0.56],0.0001556310941688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,26732,42,27.39 [12.93-58.04],5.663620191892571e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",25930,40,1.72 [1.17-2.53],0.0055666765057614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,21913,35,6.47 [2.39-17.49],0.0002333875550107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,26404,41,5.12 [3.09-8.48],2.2350874317218648e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",25812,41,1.85 [1.35-2.53],0.0001112482058321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,26739,40,13.31 [2.59-68.38],0.0019327356476598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,22544,36,4.16 [2.50-6.94],4.28447479701895e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,26416,40,2.53 [1.44-4.45],0.0013138779430362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,25946,40,1.44 [1.14-1.83],0.002266420795879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,26655,42,4.31 [2.65-7.01],4.2617637444971036e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,26416,40,7.68 [3.60-16.35],1.259098054878579e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,22882,35,2.20 [1.37-3.54],0.0011359630899709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,26416,40,1.65 [1.30-2.09],3.058547540616592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,26619,42,2.43 [1.35-4.37],0.0030459473963226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,22907,37,2.55 [1.32-4.94],0.005402435038923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,21598,33,1.48 [1.12-1.97],0.0059421598916927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,26448,39,3.77 [1.58-9.04],0.00289152343844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,26677,41,1.48 [1.20-1.81],0.0001799366556121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,25946,40,1.72 [1.15-2.58],0.0087832839751451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,22882,35,3.98 [2.27-6.97],1.3358548180952247e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,26416,40,3.94 [2.02-7.68],5.690904166039988e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,22858,36,4.05 [1.59-10.28],0.0032929988246246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,26739,40,4.18 [2.21-7.89],1.0532908852361629e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,26614,42,2.16 [1.26-3.72],0.005295580179131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,26305,39,3.66 [1.98-6.79],3.637183166567653e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFB,Platelet-derived growth factor subunit B,26539,40,1.56 [1.12-2.17],0.0087442854763326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,22293,36,2.08 [1.26-3.44],0.0042101595208128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,22429,37,3.57 [1.87-6.81],0.0001125711666706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,22963,37,3.04 [2.09-4.41],6.046542612641521e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,26732,42,3.33 [1.96-5.65],8.825837997025261e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,26587,39,2.68 [1.62-4.44],0.0001285928626524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,22666,36,5.21 [1.77-15.34],0.0027592580447953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,26036,38,1.90 [1.32-2.74],0.0005444398098959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,26072,40,3.15 [1.81-5.46],4.565237014764343e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,26404,41,4.12 [2.30-7.36],1.8074607043045327e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,26404,41,3.91 [2.28-6.73],7.803314539542503e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,26416,40,3.26 [1.85-5.75],4.55973764997816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,22945,37,10.57 [3.58-31.16],1.926832683623349e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,26490,42,3.92 [1.63-9.39],0.0022160606405596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,26217,39,11.99 [5.76-24.94],3.032790353387716e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,26611,39,2.79 [1.81-4.28],2.8517195297102885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIP,Pancreatic triacylglycerol lipase,22963,37,1.83 [1.21-2.77],0.0041995821562407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,22882,35,1.74 [1.19-2.53],0.0041902542352585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,22963,37,0.45 [0.26-0.80],0.0059989377661186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,26539,40,0.63 [0.49-0.82],0.0005967497051317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPBP,Platelet basic protein,22789,36,1.65 [1.15-2.35],0.0061487933338014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,26359,42,1.75 [1.35-2.28],2.983326794161198e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,22926,36,33.49 [13.09-85.72],2.41178738886867e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,26553,40,8.72 [5.61-13.58],8.358111456955319e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,22588,35,0.45 [0.25-0.81],0.0071020866200798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,26655,42,0.48 [0.29-0.77],0.0024578087192265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,26400,39,7.91 [2.17-28.86],0.0017270485245267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,26320,40,6.13 [3.61-10.42],2.0617601275324508e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,25754,39,1.73 [1.17-2.58],0.0063872181021447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,22713,36,2.93 [1.43-6.00],0.003370129177228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,26200,40,2.95 [1.56-5.56],0.0008340795626841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,22246,36,1.99 [1.20-3.29],0.0075833250547721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,22945,37,3.79 [2.02-7.11],3.298705088331515e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,22926,36,5.71 [1.97-16.53],0.0013273104159247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,26677,41,3.42 [2.05-5.71],2.519291551466988e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,22213,35,2.15 [1.64-2.81],2.7609387409143883e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,26409,39,8.93 [4.02-19.86],7.910438123002603e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,22495,35,1.71 [1.19-2.45],0.0033978165624537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,26402,41,0.32 [0.18-0.58],0.0001667799424936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,26539,40,2.04 [1.45-2.86],4.4988359600273777e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,22907,37,2.65 [1.79-3.93],1.264955480689003e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,26305,39,1.79 [1.28-2.50],0.0006110456393066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,26305,39,2.10 [1.37-3.22],0.0006375299752245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,26249,40,3.16 [2.25-4.43],2.8680362158124557e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,26739,40,2.29 [1.66-3.17],5.415792938913122e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,26739,40,2.23 [1.59-3.14],3.507911968938413e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,26448,39,5.43 [3.47-8.47],1.045822373774956e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,26416,40,2.25 [1.78-2.84],1.0780654194852235e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,26340,38,2.34 [1.46-3.75],0.0003816541918747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,22963,37,6.02 [3.52-10.29],5.034669339311461e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,22310,34,1.90 [1.21-2.99],0.0055280060910204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,22229,33,4.08 [2.34-7.12],7.141242708719686e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,26597,40,5.47 [3.06-9.78],9.831739510314346e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,22310,34,6.25 [3.08-12.68],3.901057569789697e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,26448,39,4.92 [1.99-12.16],0.0005473016726653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,26655,42,3.70 [2.78-4.92],3.859138760513613e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,26677,41,3.05 [1.37-6.83],0.006510984783606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,25737,40,3.89 [2.43-6.24],1.747003025880137e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,26739,40,2.18 [1.22-3.89],0.0084500149628104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,26677,41,3.29 [1.33-8.14],0.009997659229883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,26552,42,9.41 [4.75-18.64],1.2671619047524728e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,26498,40,1.46 [1.13-1.88],0.0034273437073975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,25930,40,2.38 [1.39-4.08],0.0015645392689776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,22310,34,2.04 [1.45-2.89],4.851734712274157e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,26739,40,2.95 [1.72-5.07],9.110593702947268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,26402,41,3.13 [1.81-5.41],4.509239459405445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,26416,40,4.93 [1.85-13.14],0.0014123648540254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3G,Semaphorin-3G,22429,37,2.52 [1.33-4.77],0.0046487644638042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,26640,40,4.80 [2.82-8.17],7.253818921550158e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,26739,40,2.50 [1.30-4.83],0.0061679344782716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,22561,36,6.14 [2.09-18.05],0.0009729578650804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,22968,36,13.76 [2.87-66.03],0.0010527259164539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,22631,34,7.70 [3.80-15.63],1.5626722401067294e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,26163,40,0.46 [0.28-0.74],0.0014359141223946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,22580,37,1.89 [1.23-2.90],0.0035559107797092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,22963,37,0.32 [0.18-0.58],0.000184857761294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,22926,36,4.28 [2.36-7.76],1.5863053158401833e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,26539,40,3.85 [2.49-5.95],1.413120926019117e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,26402,41,5.47 [3.38-8.85],4.3736399237064926e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,26404,41,1.65 [1.16-2.34],0.0053702157977286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,26655,42,4.18 [2.51-6.96],3.9422029470889954e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,26416,40,8.18 [3.87-17.30],3.792880644866832e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,26622,42,4.83 [2.04-11.46],0.0003521267094473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,26350,39,4.22 [2.51-7.10],6.131358392980302e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,25930,40,2.11 [1.27-3.48],0.0036349274636677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,25789,40,2.50 [1.43-4.37],0.0013084489092185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,26402,41,1.92 [1.27-2.90],0.0019003081200774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,25789,40,3.72 [2.27-6.07],1.633552559703481e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK1,SLIT and NTRK-like protein 1,22293,36,0.52 [0.33-0.81],0.0042023670436919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,26655,42,3.51 [2.29-5.39],9.723320270524936e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,22907,37,1.93 [1.20-3.13],0.007248400165317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,25789,40,4.19 [2.31-7.58],2.206354167836123e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,26384,40,2.53 [1.37-4.69],0.0031323098818543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,26404,41,3.42 [2.31-5.06],7.22219277335258e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,26402,41,3.59 [2.75-4.68],3.8846048868147815e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,26312,41,4.17 [2.00-8.67],0.0001337382189291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,26539,40,3.59 [2.00-6.42],1.721169039177763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,26448,39,3.79 [2.10-6.81],8.871026815264656e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,26384,40,0.38 [0.27-0.53],1.6344350083705268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",26739,40,5.50 [2.48-12.18],2.630277609683069e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,23481,39,6.25 [2.72-14.34],1.5686016274048798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,26194,40,0.67 [0.51-0.88],0.0033050850591603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,26490,42,6.02 [1.93-18.81],0.0020032423034962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,26281,41,2.17 [1.69-2.78],1.127624063750113e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,26498,40,3.62 [2.61-5.01],1.3313659609916664e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,26377,40,2.26 [1.66-3.08],2.105654295047208e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,26397,42,1.83 [1.28-2.63],0.001017632699818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,26402,41,2.32 [1.49-3.61],0.0001861608557724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,26684,42,2.77 [1.57-4.90],0.0004424027198304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,26490,42,3.17 [1.96-5.12],2.668386546492039e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,26416,40,3.28 [1.37-7.82],0.0074818865837158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,26404,41,3.92 [2.39-6.43],6.377897400812326e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,26103,40,5.09 [2.59-10.00],2.3202555085646377e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,26337,40,5.22 [1.64-16.58],0.0051418808356881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,22293,36,5.42 [2.57-11.46],9.348015815560027e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,22293,36,3.47 [1.45-8.32],0.0053178681447013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,22832,35,2.61 [1.31-5.20],0.0063737270972973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,26305,39,1.89 [1.35-2.64],0.0001812354641602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,25899,40,1.99 [1.39-2.85],0.0001673124832323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,26246,40,3.57 [2.65-4.83],9.244579076706056e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,26246,40,1.53 [1.25-1.89],5.7770266413094206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26732,42,4.39 [2.82-6.84],6.226098751919609e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,26400,39,4.46 [2.61-7.61],4.317536203167296e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,26490,42,4.53 [2.70-7.61],1.0987030090305854e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,26448,39,3.06 [1.98-4.75],5.538926663031315e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,26448,39,7.73 [4.21-14.21],4.4064448347430704e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,22429,37,2.95 [1.42-6.11],0.0036078458361456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,26655,42,2.57 [1.47-4.51],0.0009858834655447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,26404,41,5.97 [3.35-10.66],1.4619150781451383e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,26404,41,2.29 [1.72-3.05],1.2848384592714172e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,26684,42,3.24 [1.93-5.45],9.16038658141288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,26246,40,1.88 [1.28-2.75],0.0012141036884904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,26246,40,2.67 [1.75-4.07],4.587805533544013e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,26402,41,0.52 [0.33-0.81],0.0039908677707301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,26539,40,3.65 [1.47-9.08],0.0052829997951271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,22926,36,2.85 [1.36-5.98],0.0055927090092049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,26231,39,1.93 [1.26-2.94],0.0023931359600343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,26400,39,2.98 [1.95-4.56],5.10511598576907e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",22293,36,2.23 [1.26-3.92],0.0055658905703268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,26645,39,0.37 [0.25-0.57],3.4751654492525303e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,26454,40,5.80 [2.74-12.24],4.124689567212409e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,26645,42,1.97 [1.33-2.92],0.0006747781489443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,22293,36,4.50 [1.95-10.39],0.000427011217657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,26690,42,2.89 [1.47-5.66],0.0019842255822805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,22835,37,3.34 [2.43-4.60],1.196718540919429e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,26367,41,4.33 [2.85-6.57],6.183526675555786e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",26163,40,0.38 [0.19-0.76],0.0058976325008668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,25930,40,3.05 [1.66-5.60],0.0003303029959394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,26655,42,1.84 [1.31-2.58],0.0004447612111603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,22882,35,5.20 [2.35-11.50],4.642027448869788e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,22858,36,2.12 [1.47-3.05],6.357500589644968e-05
